← All trials
NCT00300521
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2000
- Primary completion
- —
- Completion date
- Nov 1, 2005
- First posted
- —
- Last posted
- —
- Enrollment
- 40
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- Capital Medical UniversityLead sponsor
- People's Liberation Army of ChinaCollaborator
- Capital Medical UniversityStudy director
- Huazhong University of Science and TechnologyCollaborator
- Huazhong University of Science and TechnologyStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.